Hosted on MSN12d
Study Finds Exenatide Not Beneficial for Parkinson Disease
FRIDAY, Feb. 7, 2025 (HealthDay News) -- The glucagon-like peptide-1 receptor agonist exenatide ... assigned to receive ...
infectiousdiseaseadvisor.com1d
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...
pharmaphorum1d
FDA knocks back Zealand's dasiglucagon once again
Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...
pharmaphorum7d
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...